Skip to main content
Equibles

Amundi

Position in IMVT — Immunovant, Inc.

CIK 1330387 Paris, I0
Back to IMVT Full portfolio

Position in IMVT

as of Jun 30, 2026 · filed Aug 11, 2026
Position Value
$2,733,625
+$1,073,122 QoQ
Shares Held
70,948
+6.1% QoQ
Ownership
0.034%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#77
of 226 holders
Holding Since
Dec 2022
13 quarters on record
Voting authority Sole 4% Shared 0% None 96%

Common Shares in IMVT Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Amundi holds $2,427,267,538 across 70 Biotechnology names. IMVT ranks #17 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 1,546,509 $768,197,412
2 REGN
Regeneron Pharmaceuticals, Inc.
 1,013,540 $631,982,729
3 RPRX
Royalty Pharma plc
 3,723,864 $208,797,052
4 ALNY
Alnylam Pharmaceuticals, Inc.
 617,471 $185,877,294
5 INCY
Incyte Corp
 1,181,498 $133,934,612
6 TECH
BIO-TECHNE Corp
 1,827,241 $129,094,576
7 MRNA
Moderna, Inc.
 888,779 $62,241,193
8 ARGX
Argenx SE
 65,122 $60,418,237

All Filings in IMVT

Export CSV
13 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,733,625 70,948
2026-03-31 $1,660,503 66,848
2025-12-31 $1,713,409 67,404
2025-03-31 $44,314 2,593
2024-12-31 $64,228 2,593
2024-09-30 $73,926 2,593
2024-06-30 $84,849 3,214
2024-03-31 $103,844 3,214
2023-12-31 $135,405 3,214
2023-09-30 $138,818 3,616
2023-06-30 $68,595 3,616
2023-03-31 $56,084 3,616
2022-12-31 $64,184 3,616